Youth and hormone receptors in breast cancer: good or bad news first?
Stockler
M
M
Department of Medicine, University of Sydney, National Health and Medical Research Council Clinical Trials Centre, Camperdown, NSW, Australia.
Beith
J
J
D000328:Adult; D000367:Age Factors; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008875:Middle Aged; D010053:Ovary / Q000601:surgery; D017697:Premenopause; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism*; D013629:Tamoxifen / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D011960:Receptors, Estrogen; D013629:Tamoxifen